• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number RONYX35030UX
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Myocardial Infarction (1969); Occlusion (1984); Thrombus (2101)
Date of Event 11/03/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
During the index procedure one resolute onyx drug eluting stent was implanted in the lad.Approximately 8 months later the patient suffered mi of the lad (target vessel).The event was treated with hospitalization and an integrillin drip which was later stopped.It was reported 100% occlusion occurred in lad and lcx and residual thrombus still present after cath.The patient recovered.The investigator and the sponsor assessed the event as not related to the anti-platelet medication or the device.
 
Additional Manufacturer Narrative
Additional information: coronary artery stent thrombosis also occurred which was treated with medication the investigator and sponsor assessed event coronary stent thrombosis is possibly related to device and not related to the anti platelets.Revascularization of the lad (target vessel) was carried out to treat the mi and stent thrombosis.Cec adjudicated the mi as a non-q-wave mi of the target vessel, 3rd udmi spontaneous.Cec also adjudicated late stent thrombosis (arc defined).Cec commented that it was noted 100% svg to lad thrombosis treated with laser.Cec adjudicated revascularization as a clinically driven target lesion revascularization.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Common Device Name
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key9784595
Report Number9612164-2020-00981
Device Sequence Number13593074
Product Code NIQ
UDI-Device Identifier00643169557116
UDI-Public00643169557116
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P160043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date12/04/2020
Device Model NumberRONYX35030UX
Device Catalogue NumberRONYX35030UX
Device Lot Number0009473461
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/20/2020
Supplement Date Received by Manufacturer02/28/2020
Initial Report FDA Received Date03/04/2020
Supplement Report FDA Received Date03/16/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Other;
Patient Age73 YR
Patient Weight79
-
-